{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:26:44Z","timestamp":1770816404521,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To evaluate the long-term outcome after re-attempt CTO-PCI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective cohort study that included 113 re-attempt CTO-PCI patients who were consecutively registered from January 2019 to December 2020 at Beijing Anzhen Hospital's Center of Coronary Artery Disease. All patients were divided into two groups based on procedural success or failure. The primary endpoint was major adverse cardiac events (MACE), a composite of all-cause mortality, myocardial infarction and target vessel revascularization (TVR). The secondary endpoint was angina after PCI.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, the successful re-attempt CTO-PCI was archived in 77 patients, the failed CTO-PCI was performed in 36 patients. After a median follow-up of 21.7\u00a0months (interquartile range: 10.9\u201326.0), the incidence of the primary outcome was significantly lower in the success group [14.2% vs. 38.9%, adjusted hazard ratio (HR) 0.351, 95% CI 0.134\u20130.917, P\u2009=\u20090.033], mainly driven by the reduction of TVR (9.1% vs. 30.6%, adjusted HR 0.238, 95% CI: 0.078\u20130.72, P\u2009=\u20090.011). Furthermore, patients who had successful re-attempt CTO-PCI had a lower risk of angina after PCI (27.3% vs.61.1%, adjusted HR 0.357, 95% CI 0.167\u20130.76, P\u2009=\u20090.008). The risk factors of TVR in the patients with successful re-attempt CTO-PCI were stent length &gt;\u2009100\u00a0mm (adjusted HR 21.805, 95% CI 1.765\u2013269.368, P\u2009=\u20090.016) and J-CTO score\u2009&gt;\u20093(adjusted HR: 9.733, 95% CI:1.533\u201361.797, P\u2009=\u20090.016).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For the patients with previous CTO-PCI failure, a successful re-attempt CTO-PCI was associated with significantly lower MACE, which was primarily driven by a lower TVR rate. More complex CTO lesions and longer stents were the independent predictors of TVR after successful CTO-PCI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03045-w","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T15:02:57Z","timestamp":1673881377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long term clinical outcome after success re-attempt percutaneous coronary intervention of chronic total occlusion"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenzheng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5545-7492","authenticated-orcid":false,"given":"Jinghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"3045_CR1","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/CIRCULATIONAHA.118.031313","volume":"139","author":"S-GS-WWSG Lee","year":"2019","unstructured":"Lee S-GS-WWSG, Lee PH, Ahn J-MM, Park D-WW, Yun S-CC, Han S, et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion: the DECISION-CTO trial. Circulation. 2019;139:1674\u201383. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.031313.","journal-title":"Circulation"},{"key":"3045_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jcin.2020.10.003","volume":"14","author":"C Guan","year":"2021","unstructured":"Guan C, Yang W, Song L, Chen J, Qian J, Wu F, et al. Association of acute procedural results with long-term outcomes after CTO PCI. JACC Cardiovasc Interv. 2021;14:278\u201388. https:\/\/doi.org\/10.1016\/j.jcin.2020.10.003.","journal-title":"JACC Cardiovasc Interv"},{"key":"3045_CR3","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1136\/heartjnl-2015-308891","volume":"102","author":"WM Wilson","year":"2016","unstructured":"Wilson WM, Walsh SJ, Yan AT, Hanratty CG, Bagnall AJ, Egred M, et al. Hybrid approach improves success of chronic total occlusion angioplasty. Heart. 2016;102:1486\u201393.","journal-title":"Heart"},{"key":"3045_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jcin.2010.09.024","volume":"4","author":"Y Morino","year":"2011","unstructured":"Morino Y, Abe M, Morimoto T, Kimura T, Hayashi Y, Muramatsu T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30\u00a0minutes. JACC Cardiovasc Interv. 2011;4:213\u201321. https:\/\/doi.org\/10.1016\/j.jcin.2010.09.024.","journal-title":"JACC Cardiovasc Interv"},{"key":"3045_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000617","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018. https:\/\/doi.org\/10.1161\/CIR.0000000000000617.","journal-title":"J Am Coll Cardiol"},{"key":"3045_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.amjcard.2015.02.038","volume":"115","author":"GE Christakopoulos","year":"2015","unstructured":"Christakopoulos GE, Christopoulos G, Carlino M, Jeroudi OM, Roesle M, Rangan BV, et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol. 2015;115:1367\u201375. https:\/\/doi.org\/10.1016\/j.amjcard.2015.02.038.","journal-title":"Am J Cardiol"},{"key":"3045_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1161\/CIRCULATIONAHA.119.039797","volume":"140","author":"ES Brilakis","year":"2019","unstructured":"Brilakis ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, Alaswad K, Araya M, et al. Guiding principles for chronic total occlusion percutaneous coronary intervention: a global expert consensus document. Circulation. 2019;140:420\u201333.","journal-title":"Circulation"},{"key":"3045_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ahj.2010.04.015","volume":"160","author":"D Joyal","year":"2010","unstructured":"Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. Am Heart J. 2010;160:179\u201387. https:\/\/doi.org\/10.1016\/j.ahj.2010.04.015.","journal-title":"Am Heart J"},{"key":"3045_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.carrev.2020.10.006","volume":"25","author":"W Abuzeid","year":"2021","unstructured":"Abuzeid W, Zivkovic N, Elbaz-Greener G, Yaranton B, Patel V, Strauss B, et al. Association between revascularization and quality of life in patients with coronary chronic total occlusions: a systematic review. Cardiovasc Revasc Med. 2021;25:47\u201354. https:\/\/doi.org\/10.1016\/j.carrev.2020.10.006.","journal-title":"Cardiovasc Revasc Med"},{"key":"3045_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijcard.2011.04.023","volume":"161","author":"F Borgia","year":"2012","unstructured":"Borgia F, Viceconte N, Ali O, Stuart-Buttle C, Saraswathyamma A, Parisi R, et al. Improved cardiac survival, freedom from mace and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions. Int J Cardiol. 2012;161:31\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2011.04.023.","journal-title":"Int J Cardiol"},{"key":"3045_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jcin.2014.10.010","volume":"8","author":"WJ Jang","year":"2015","unstructured":"Jang WJ, Yang JH, Choi SH, Bin SY, Hahn JY, Choi JH, et al. Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation. JACC Cardiovasc Interv. 2015;8:271\u20139.","journal-title":"JACC Cardiovasc Interv"},{"key":"3045_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/ccd.28104","volume":"93","author":"M Abe","year":"2019","unstructured":"Abe M, Morimoto T, Morino Y, Tanaka H, Akao M, Hayashi Y, et al. Association between J-CTO score and long-term target lesion revascularization rate after successful chronic total coronary occlusion angioplasty (from the J-CTO registry). Catheter Cardiovasc Interv. 2019;93:1025\u201332.","journal-title":"Catheter Cardiovasc Interv"},{"key":"3045_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13368","author":"T Tian","year":"2021","unstructured":"Tian T, Guan C, Gao L, Yuan J, Cui J, Hu F, et al. Predictors for adverse outcomes of patients with recanalized chronic total occlusion lesion. Eur J Clin Invest. 2021. https:\/\/doi.org\/10.1111\/eci.13368.","journal-title":"Eur J Clin Invest"},{"key":"3045_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/jcm9010178","volume":"9","author":"M Geyer","year":"2020","unstructured":"Geyer M, Wild J, Hirschmann M, Dimitriadis Z, M\u00fcnzel T, Gori T, et al. Predictors for target vessel failure after recanalization of chronic total occlusions in patients undergoing surveillance coronary angiography. J Clin Med. 2020;9:178.","journal-title":"J Clin Med"},{"key":"3045_CR15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.4244\/EIJV9I10A199","volume":"9","author":"J Gomez-Lara","year":"2014","unstructured":"Gomez-Lara J, Teruel L, Homs S, Ferreiro JL, Romaguera R, Roura G, et al. Lumen enlargement of the coronary segments located distal to chronic total occlusions successfully treated with drug-eluting stents at follow-up. EuroIntervention. 2014;9:1181\u20138. https:\/\/doi.org\/10.4244\/EIJV9I10A199.","journal-title":"EuroIntervention"},{"key":"3045_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ccd.28143","volume":"94","author":"Y Okuya","year":"2019","unstructured":"Okuya Y, Saito Y, Takahashi T, Kishi K, Hiasa Y. Novel predictors of late lumen enlargement in distal reference segments after successful recanalization of coronary chronic total occlusion. Catheter Cardiovasc Interv. 2019;94:546\u201352.","journal-title":"Catheter Cardiovasc Interv"},{"key":"3045_CR17","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.cjca.2014.07.016","volume":"30","author":"AR Galassi","year":"2014","unstructured":"Galassi AR, Boukhris M, Tomasello SD, Marz\u00e0 F, Azzarelli S, Giubilato S, et al. Long-term clinical and angiographic outcomes of the mini-STAR technique as a bailout strategy for percutaneous coronary intervention of chronic total occlusion. Can J Cardiol. 2014;30:1400\u20136. https:\/\/doi.org\/10.1016\/j.cjca.2014.07.016.","journal-title":"Can J Cardiol"},{"key":"3045_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/ccd.27783","volume":"93","author":"PJ Goleski","year":"2019","unstructured":"Goleski PJ, Nakamura K, Liebeskind E, Salisbury AC, Grantham JA, McCabe JM, et al. Revascularization of coronary chronic total occlusions with subintimal tracking and reentry followed by deferred stenting: experience from a high-volume referral center. Catheter Cardiovasc Interv. 2019;93:191\u20138.","journal-title":"Catheter Cardiovasc Interv"},{"key":"3045_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/ccd.25509","volume":"85","author":"G Visconti","year":"2015","unstructured":"Visconti G, Focaccio A, Donahue M, Briguori C. Elective versus deferred stenting following subintimal recanalization of coronary chronic total occlusions. Catheter Cardiovasc Interv. 2015;85:382\u201390.","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03045-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03045-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03045-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T03:47:51Z","timestamp":1674272871000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03045-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3045"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03045-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Beijing Anzhen Hospital's Research Committee authorized all of the study's protocols, which followed the 1964 Declaration of Helsinki (2021115X). Because this was an observational retrospective study, patient consent was not required, all data were gathered from medical records.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}